ACE and benign prostatic hyperplasia: In all age groups, women had a higher prescription prevalence for most pharmacological groups except for drugs used in benign prostatic hypertrophy, anti-gout preparations and drugs used to treat cardiovascular disease (including anti-lipemic agents, beta- blockers and related medicines and angiotensin – converting enzyme inhibitors).